Cargando…
The Antiarrhythmic Mechanisms of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe yet rare inherited arrhythmia disorder. The cornerstone of CPVT medical therapy is the use of β-blockers; 30% of patients with CPVT do not respond well to optimal β-blocker treatment. Studies have shown that flecainide effectiv...
Autores principales: | Li, Yukun, Peng, Xiaodong, Lin, Rong, Wang, Xuesi, Liu, Xinmeng, Bai, Rong, Ma, Changsheng, Tang, Ribo, Ruan, Yanfei, Liu, Nian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959698/ https://www.ncbi.nlm.nih.gov/pubmed/35356081 http://dx.doi.org/10.3389/fphys.2022.850117 |
Ejemplares similares
-
Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
por: Pölönen, R. P., et al.
Publicado: (2018) -
Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
por: Hwang, Hyun Seok, et al.
Publicado: (2019) -
Insights on the mechanism of flecainide in catecholaminergic polymorphic ventricular tachycardia
por: Davidson, Ross, et al.
Publicado: (2023) -
Questioning flecainide's mechanism of action in the treatment of catecholaminergic polymorphic ventricular tachycardia
por: Williams, Alan J., et al.
Publicado: (2016) -
Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis
por: Wang, Guangqiang, et al.
Publicado: (2019)